Mycobacterium-kannat

This tender for Genotype Testing for Mycobacterium is generally well-structured, with clear technical requirements and a defined scope. However, it lacks specific evaluation criteria and details on the submission process, impacting its overall quality.

The tender adheres to open procedure and specifies a CPV code. Deadlines are provided, though the submission deadline might be considered short given the complexity. No disputes are noted. Regulatory compliance is assumed but not explicitly detailed.

The description of the required Genotype Testing solution is clear and detailed, outlining the need for an end-to-end automated molecular process. The AI-extracted requirements further clarify the technical specifications.

Basic information such as title, organization, estimated value, and contract duration are present. However, the lack of available document content and specified evaluation criteria leaves gaps in completeness.

The tender appears fair, with a disclosed estimated value and objective technical requirements. The open procedure suggests broad access. However, the absence of explicit evaluation criteria could lead to subjective assessments.

While a contract start date and duration are specified, the lack of information regarding e-submission and the URL for tender documents hinders practical accessibility. Financing information is not detailed.

Key fields like title, reference, organization, value, and dates are populated logically. No suspension or disputes are reported, indicating good data consistency.

The tender does not explicitly mention green procurement, social aspects, or innovation. It is also not indicated as EU funded, suggesting a limited focus on sustainability criteria.